{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:55:06Z","timestamp":1791312906713,"version":"4.3.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.thromres.2010.06.017","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T09:01:58Z","timestamp":1279184518000},"page":"e167-e174","source":"Crossref","is-referenced-by-count":119,"title":["French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)"],"prefix":"10.1016","volume":"126","author":[{"given":"Gilles","family":"Pernod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Godi\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gozalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Tremey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Si\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2010.06.017_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1055\/s-0038-1656064","article-title":"A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses","volume":"77","author":"Pengo","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.06.017_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-141-10-200411160-00005","article-title":"Advanced age, anticoagulation intensity, and risk for intracranial haemorrhage among patients taking warfarin for atrial fibrillation","volume":"141","author":"Fang","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib4","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1378\/chest.126.6.1938","article-title":"Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis","volume":"126","author":"Reynolds","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2010.06.017_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-135-6-200109180-00008","article-title":"Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin","volume":"135","author":"Hylek","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.7326\/0003-4819-126-12-199706150-00005","article-title":"Correction of excessive anticoagulation with low-dose oral vitamin K1","volume":"126","author":"Weibert","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib7","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.163.20.2469","article-title":"Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study","volume":"163","author":"Lubetsky","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib8","first-page":"137","article-title":"Oral vitamin K produces a normal INR within 24hours of its administration in most patients discontinuing warfarin","volume":"90","author":"Crowther","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2010.06.017_bib9","first-page":"391","article-title":"Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis","volume":"166","author":"DeZee","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2010.06.017_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1538-7836.2009.03652.x","article-title":"Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study","volume":"8","author":"Kim","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.06.017_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11239-008-0211-4","article-title":"Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1, 043 cases","volume":"27","author":"Denas","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2010.06.017_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-150-5-200903030-00005","article-title":"Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial","volume":"150","author":"Crowther","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","article-title":"Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance centres","volume":"320","author":"Pouyanne","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/j.thromres.2010.06.017_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0002-9343(87)90004-0","article-title":"Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy","volume":"82","author":"Landefeld","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(89)80689-8","article-title":"Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy","volume":"87","author":"Landefeld","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-118-7-199304010-00005","article-title":"Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group","volume":"118","author":"Fihn","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archinte.160.4.470","article-title":"Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study","volume":"160","author":"Palareti","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihaemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.06.017_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00277-002-0568-y","volume":"82","author":"Yasaka","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.thromres.2010.06.017_bib21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.STR.0000221786.81354.d6","article-title":"Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates","volume":"37","author":"Huttner","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2010.06.017_bib22","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1365-2141.2001.03214.x","article-title":"Beriplex P\/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding","volume":"115","author":"Evans","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2010.06.017_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2004.04.004","article-title":"Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation","volume":"113","author":"Lubetsky","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2010.06.017_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.thromres.2004.09.002","article-title":"Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation","volume":"115","author":"Yasaka","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2010.06.017_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00134-007-0528-z","article-title":"Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage","volume":"33","author":"Vigue","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0038-1655992","article-title":"Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy","volume":"77","author":"Makris","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.06.017_bib27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00006123-199911000-00020","article-title":"Use of factor IX complex in warfarin-related intracranial hemorrhage","volume":"45","author":"Boulis","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.thromres.2010.06.017_bib28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/02688690050175265","article-title":"Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies","volume":"14","author":"Cartmill","year":"2000","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.thromres.2010.06.017_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3171\/jns.2003.98.4.0737","article-title":"The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings","volume":"98","author":"Lin","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.thromres.2010.06.017_bib30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1592\/phco.26.8.1091","article-title":"Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin","volume":"26","author":"Dager","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.thromres.2010.06.017_bib31","first-page":"230","volume":"28","author":"Vahanian","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2010.06.017_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000094831","article-title":"Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee","volume":"22","author":"Steiner","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.thromres.2010.06.017_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/str.19.3.407b","article-title":"Resumption of anticoagulation after intracranial bleeding in patients with prosthetic heart valves","volume":"19","author":"Babikian","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2010.06.017_bib34","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1046\/j.1365-2141.1998.01078.x","article-title":"Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up","volume":"103","author":"Butler","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2010.06.017_bib35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00006123-199804000-00053","article-title":"The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves","volume":"42","author":"Wijdicks","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.thromres.2010.06.017_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1067\/mjd.2003.47","article-title":"Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation","volume":"48","author":"Kovich","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.thromres.2010.06.017_bib37","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jcrs.2006.02.035","article-title":"Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel","volume":"32","author":"Kumar","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.thromres.2010.06.017_bib38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1055\/s-2006-925086","article-title":"Board of the French Society for Digestive Endoscopy (SFED). Guidelines of the French Society for Digestive Endoscopy (SFED)","volume":"38","author":"Napol\u00e9on","year":"2006","journal-title":"Endoscopy"},{"key":"10.1016\/j.thromres.2010.06.017_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2010.06.017_bib40","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/jama.1978.03280350062016","article-title":"Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations","volume":"239","author":"Tinker","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2010.06.017_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.163.8.901","article-title":"Perioperative management of patients receiving oral anticoagulants: a systematic review","volume":"163","author":"Dunn","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinternmed.2007.23","article-title":"Risk of Thromboembolism With Short-term Interruption of Warfar in Therapy","volume":"168","author":"Garcia","year":"2008","journal-title":"Arch Int Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib43","first-page":"CD001927","article-title":"Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks","volume":"3","author":"Aguilar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2010.06.017_bib44","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2010.06.017_bib45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM197910183011602","article-title":"Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis","volume":"301","author":"Hull","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib46","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1055\/s-0038-1649783","article-title":"Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis","volume":"74","author":"Levine","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.06.017_bib47","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1538-7836.2004.00698.x","article-title":"Comparison of 1month with 3months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor","volume":"2","author":"Kearon","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.06.017_bib48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.CIR.67.4.901","article-title":"The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge","volume":"67","author":"Hull","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2010.06.017_bib49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2009.03685.x","article-title":"Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?","volume":"8","author":"Steib","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.06.017_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1538-7836.2009.03649.x","article-title":"Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin","volume":"8","author":"Malato","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.06.017_bib51","first-page":"392","article-title":"Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review","volume":"8","author":"Carrel","year":"1999","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.thromres.2010.06.017_bib52","first-page":"542","article-title":"The management of patients on chronic coumadin therapy undergoing subsequent surgical procedures","volume":"60","author":"Madura","year":"1994","journal-title":"Am Surg"},{"key":"10.1016\/j.thromres.2010.06.017_bib53","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1538-7836.2006.01908.x","article-title":"Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry","volume":"4","author":"Spyropoulos","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.06.017_bib54","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9149(99)00341-0","article-title":"Use of enoxaparin for the chronically anticoagulated patient before and after procedures","volume":"84","author":"Spandorfer","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2010.06.017_bib55","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1345\/aph.10305","article-title":"Dalteparin as periprocedure anticoagulation for patients on warfarine and at high risk of thrombosis","volume":"35","author":"Tinmouth","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.thromres.2010.06.017_bib56","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1378\/chest.120.6.1972","article-title":"Treatment of warfarin-associated coagulopathy: a physician survey","volume":"120","author":"Wilson","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2010.06.017_bib57","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarine: assessment of a standardized periprocedural anticoagulation regimen","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2010.06.017_bib58","first-page":"1518","article-title":"Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin","volume":"21","author":"Kovacs","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2010.06.017_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11239-005-3120-9","article-title":"Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol","volume":"20","author":"Jaffer","year":"2005","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2010.06.017_bib60","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2010.06.017_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc8186","article-title":"Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding","volume":"13","author":"Schick","year":"2009","journal-title":"Crit Care"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810003579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810003579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T02:41:45Z","timestamp":1559270505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384810003579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0049384810003579"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2010.06.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}